Saakh Pharma

Saakh Pharma Ltd. stands as the primary entity within the Saakh Group, a diversified conglomerate focused on the pharmaceutical and healthcare sectors. Established in 2014, the company specializes in the critical manufacturing of Active Pharmaceutical Ingredients (APIs), alongside robust capabilities in drug formulation and nutraceuticals production. The broader Saakh Group strategically integrates specialized entities such as CKD Pharma, Focus & Rulz Pharmaceuticals, and Saakh Technologies, collectively spanning the entire pharmaceutical value chain. This integrated approach ensures comprehensive control and innovation across all stages of product development and delivery, aiming to significantly empower healthcare systems globally through its high-quality offerings and advanced technological integration.

Operating with a significant footprint, Saakh Pharma maintains operations across two distinct locations, supporting a dedicated workforce ranging from 500 - 1,000 employees. The company generates substantial revenue, reported at $42.1M, underscoring its market presence and operational scale. This robust infrastructure and skilled team are instrumental in driving the company's mission forward. For insights into the individuals steering these operations and their expertise, one can explore Meet Saakh Pharma's team. Their commitment to excellence is evident in their continuous pursuit of advanced manufacturing processes and product development, contributing to their expansive market reach and operational efficiency.

The company's strategic vision centers on empowering healthcare by delivering superior products and leveraging cutting-edge technologies. Saakh Pharma's dedication to innovation and quality positions it as a key player in the pharmaceutical landscape, particularly within its operational regions. By focusing on the entire pharmaceutical value chain, from API synthesis to finished formulations, SaakhView more...